LENZ Therapeutics, Inc. short interest in 2025
In 2025, LENZ Therapeutics, Inc.'s disclosed short interest ran from 8.92% of shares outstanding on 15 Jan 2025 to 24.57% on 31 Dec 2025, a change of +15.65 percentage points. The year's high was 27.37% on 14 Nov 2025 and its low 8.92% on 15 Jan 2025, averaging 15.34% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 31.38 days on 14 Feb 2025. Full history: LENZ Therapeutics, Inc..
Cite this page
By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2025 in figures
- Start of year
- 8.92% (15 Jan 2025)
- End of year
- 24.57% (31 Dec 2025)
- Change
- +15.65 pp
- High
- 27.37% (14 Nov 2025)
- Low
- 8.92% (15 Jan 2025)
- Average
- 15.34%
- Highest days to cover
- 31.38 (14 Feb 2025)
- SEC filings marked
- 9
Every report in 2025
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2025 | 8.92% | 13.50 | |
| 31 Jan 2025 | 9.05% | 14.77 | |
| 14 Feb 2025 | 9.29% | 31.38 | |
| 28 Feb 2025 | 9.27% | 27.56 | |
| 14 Mar 2025 | 9.43% | 10.88 | |
| 31 Mar 2025 | 9.11% | 9.39 | 10-K filed, results (8-K) |
| 15 Apr 2025 | 10.51% | 8.50 | results (8-K) |
| 30 Apr 2025 | 11.59% | 11.55 | |
| 15 May 2025 | 12.26% | 15.39 | 10-Q filed, results (8-K) |
| 30 May 2025 | 12.10% | 23.88 | |
| 13 Jun 2025 | 12.35% | 10.36 | |
| 30 Jun 2025 | 13.32% | 9.40 | |
| 15 Jul 2025 | 13.97% | 12.83 | |
| 31 Jul 2025 | 13.40% | 15.23 | 10-Q filed, results (8-K) |
| 15 Aug 2025 | 16.90% | 4.98 | |
| 29 Aug 2025 | 17.36% | 9.67 | |
| 15 Sep 2025 | 17.60% | 13.52 | |
| 30 Sep 2025 | 18.48% | 12.69 | |
| 15 Oct 2025 | 19.83% | 4.72 | |
| 31 Oct 2025 | 23.11% | 6.47 | |
| 14 Nov 2025 | 27.37% | 5.15 | 10-Q filed, results (8-K) |
| 28 Nov 2025 | 25.44% | 9.47 | |
| 15 Dec 2025 | 22.93% | 5.09 | |
| 31 Dec 2025 | 24.57% | 8.96 |
See also: LENZ Therapeutics, Inc.'s full history · most shorted US stocks of 2025 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.